Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience

Objectives: Remdesivir is currently approved for the treatment of COVID-19. The recommendation for using remdesivir in patients with COVID-19 was based on the in vitro and in vivo activity of this drug against SARS-CoV-2. Methods: This was a prospective observational study conducted on a population...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Alessandro, Binetti, Erica, Borrazzo, Cristian, Cacciola, Elio Gentilini, Battistini, Luigi, Ceccarelli, Giancarlo, Mastroianni, Claudio Maria, d’Ettorre, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432083/
https://www.ncbi.nlm.nih.gov/pubmed/34501233
http://dx.doi.org/10.3390/jcm10173784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432083/
https://www.ncbi.nlm.nih.gov/pubmed/34501233
http://dx.doi.org/10.3390/jcm10173784

Ejemplares similares